Currently, there are two options available in the U.S.: Xultophy (iDegLira), a once-daily injection that combines Tresiba (insulin degludec, a basal insulin) with Victoza (liraglutide) Soliqua (iGlarLixi), a once-daily injection that combines Lantus (insulin glargine, a basal insulin) with Adlyxin (lixisenatide) Dr
Prescribing trends of glucagon-like peptide 1 receptor agonists for type 2 diabetes or obesity
How long did it take to see weight loss results
In parallel, oxidative stress contributes to pathogenesis through an imbalance between pro-oxidant and antioxidant systems, promoting cellular injury and immune dysfunction
People who are living with these medications are swapping notes with each other in real time, sharing experiences that rarely make it into a doctors office visit or an official report. As social media use has expanded, it has become a more valuable source of health-related data, even as access to that data has grown more restricted
Has there been any studies specifically of vaping or people smoking marijuana and all-cause mortality